The article focuses on the prognosis of synchronous bilateral breast cancer (SBBC) among women in Great Britain. The treatment of SBBC is based on its worsening condition. As perceived, the adjuvant systemic therapy has been recommended for tumours with worst prognosis. Moreover, the surgery for SBBC varies according to the size and distribution of tumour.